Coventry patients demand inquiry after chemotherapy review finds serious harm
A review of 20 cases at an NHS trust found six patients suffered severe harm. Patients and their lawyers want a wider public inquiry.

Review information is loading.
Patients treated by University Hospitals Coventry and Warwickshire NHS Trust are calling for a public inquiry after a review found serious harm among people given prolonged chemotherapy for brain tumours.
The Royal College of Physicians (RCP) examined 20 cases under the care of retired oncologist Professor Ian Brown. According to PA Media, the review judged care unsatisfactory in 15 cases and in need of improvement in the other five. It classified the harm as severe in six cases, moderate in five and low in eight; in the remaining case, reviewers could not decide between moderate and severe harm.
The 20 cases were a selected group, not all patients who received the treatment. The trust previously told ITV News that the review covered a group who had received more than 12 cycles of the chemotherapy drug temozolomide between 2017 and 2023. The BBC reported that 83 patients received extended treatment during that period. How many patients outside the reviewed cases suffered harm remains unclear.
Temozolomide is used to treat some brain tumours, typically for six cycles after radiotherapy. The review found that some patients received it for years, sometimes despite evidence of toxicity or deterioration. It also found that some patients had been misdiagnosed or given misleading information, including that they would die if they stopped treatment.
Becky Jones told the BBC she had 11 years of chemotherapy after being told she had a brain tumour. After more than 100 cycles, doctors found she had never had a tumour and that her scans were consistent with tumefactive demyelination, a different kind of lesion.
“A national inquiry needs to happen and things need to be tightened up so it can't happen to anyone else,” she said. Law firm Brabners, which represents more than 40 patients, is also calling for an independent public inquiry.
The RCP review criticised oversight at the trust and found that opportunities to challenge the treatment had been missed, PA Media reported. Brown did not participate in the review and refused to comment when approached by the BBC.
The trust apologised to patients and families for failures in its neuro-oncology service. It said it had extended its historical review back to 2005 and would arrange an independent external clinical review for all living patients who received more than 12 cycles under Brown.
The trust also said it had begun discussions with NHS England about how to review the cases of patients who received the non-standard treatment and have since died.
Sign in to give this article a thumbs up or down.
From the discussion
Private test discussion. Comments are readers’ views and are not yet automatically fact-checked. Editing is available for 60 seconds after posting.
Sign in with a confirmed reader account and choose a username to read comments and participate.
Sorting applies to top-level comments; replies remain oldest first. New comments and likes can change the order. Refresh for the current ranking.
Loading comments…